Genexine-Kalbe Indonesia JV To Target Biologic Production
This article was originally published in PharmAsia News
South Korean biotech firm Genexine is to set up its fifth joint venture as part of a global push, this time with Kalbe Farma in Indonesia. The venture, KG Bio, will develop and seek regulatory approvals of Genexine's hyFc technology based protein therapies, and Genexine plans to use the new business to strengthen its ASEAN and international business.
Register for our free email digests: